Thrivent Financial for Lutherans’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $204K | Hold |
|
|||||
|
2024
Q4 | $204K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $212K | Sell |
|
|||||
|
2022
Q4 | $215K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $201K | Sell |
|
|||||
|
2022
Q1 | $475K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $254K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $225K | Hold |
|
|||||
|
2020
Q1 | $225K | Buy |
|
|||||
|
2019
Q4 | $227K | Sell |
|
|||||
|
2019
Q3 | $350K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $17K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $611 | Buy |
|